52 related articles for article (PubMed ID: 33039851)
1. Prognostic Factors and Resectability Predictors in Insular Gliomas: A Systematic Review.
Papadopoulou A; Kumar NS
J Neurol Surg A Cent Eur Neurosurg; 2024 Jan; 85(1):74-87. PubMed ID: 37619597
[TBL] [Abstract][Full Text] [Related]
2. Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland.
Nurminen R; Afyounian E; Paunu N; Katainen R; Isomäki M; Nurminen A; Scaravilli M; Tolppanen J; Fey V; Kivinen A; Helén P; Välimäki N; Kesseli J; Aaltonen LA; Haapasalo H; Nykter M; Rautajoki KJ
Sci Rep; 2024 May; 14(1):11562. PubMed ID: 38773237
[TBL] [Abstract][Full Text] [Related]
3. Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the Gliogene Consortium.
Jalali A; Amirian ES; Bainbridge MN; Armstrong GN; Liu Y; Tsavachidis S; Jhangiani SN; Plon SE; Lau CC; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Muzny DM; Gibbs RA; Melin BS; Bondy ML
Sci Rep; 2015 Feb; 5():8278. PubMed ID: 25652157
[TBL] [Abstract][Full Text] [Related]
4. Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas-A Single-Institution, Nine-Year Data.
Lasica AB; Jaunmuktane Z; Fersht N; Kirkman MA; Dixon L; Hoskote C; Brandner S; Samandouras G
World Neurosurg; 2021 Jul; 151():e217-e233. PubMed ID: 33866029
[TBL] [Abstract][Full Text] [Related]
5. Mapping and anatomo-surgical techniques for SMA-cingulum-corpus callosum gliomas; how I do it.
Klitsinikos D; Ekert JO; Carels A; Samandouras G
Acta Neurochir (Wien); 2021 May; 163(5):1239-1246. PubMed ID: 33779836
[TBL] [Abstract][Full Text] [Related]
6. Commentary: Postacute Cognitive Rehabilitation for Adult Brain Tumor Patients.
Sefcikova V; Christofi G; Samandouras G
Neurosurgery; 2021 Nov; 89(6):E295-E297. PubMed ID: 33763696
[No Abstract] [Full Text] [Related]
7. Systematic review-Time to malignant transformation in low-grade gliomas: Predicting a catastrophic event with clinical, neuroimaging, and molecular markers.
Satar Z; Hotton G; Samandouras G
Neurooncol Adv; 2021; 3(1):vdab101. PubMed ID: 34466805
[TBL] [Abstract][Full Text] [Related]
8. Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients' relatives.
Alanen E; Heikkinen S; Nurminen R; Nykter M; Haapasalo H; Hirvonen E; Pitkäniemi J; Rautajoki KJ
Neurooncol Adv; 2023; 5(1):vdad008. PubMed ID: 36950216
[TBL] [Abstract][Full Text] [Related]
9. Molecular Classification of Diffuse Gliomas.
Kalidindi N; Or R; Babak S; Mason W
Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in non-syndromic, familial gliomas in first degree relatives: A systematic review.
Vasilica AM; Sefcikova V; Samandouras G
Clin Neurol Neurosurg; 2020 Nov; 198():106222. PubMed ID: 33039851
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H
J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
[TBL] [Abstract][Full Text] [Related]
15. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas.
Idbaih A; Boisselier B; Sanson M; Crinière E; Liva S; Marie Y; Carpentier C; Paris S; Laigle-Donadey F; Mokhtari K; Kujas M; Hoang-Xuan K; Delattre O; Delattre JY
Cancer Genet Cytogenet; 2007 Jul; 176(2):121-6. PubMed ID: 17656254
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
